Cargando…

Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards

Molecular tumor boards (MTBs) require specialized activities to leverage genomic data for therapeutic decision-making. Currently, there are no defined standards for implementing, executing, and tracking the impact of MTBs. This study describes the development and validation of ACTE-MTB, a tool to ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Love, Tara M., Anaya, Daniel A., Prime, Matthew S., Ardolino, Luke, Ekinci, Okan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106161/ https://www.ncbi.nlm.nih.gov/pubmed/35560035 http://dx.doi.org/10.1371/journal.pone.0268477

Ejemplares similares

Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting
por: VanderWalde, Ari, et al.
Publicado: (2020)

Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
por: Basse, Clémence, et al.
Publicado: (2018)

Digital Tumor Board Solutions Have Significant Impact on Case Preparation
por: Hammer, Richard D., et al.
Publicado: (2020)

Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers
por: Frank, Benedikt, et al.
Publicado: (2022)

Game Development Tool Essentials
por: Ardolino, Alessandro
Publicado: (2014)

Software-Tool Support for Collaborative, Virtual, Multi-Site Molecular Tumor Boards
por: Schapranow, Matthieu-P., et al.
Publicado: (2023)

A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB
por: Beutler, Markus, et al.
Publicado: (2020)

Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care
por: Vingiani, Andrea, et al.
Publicado: (2023)

Impact of multidisciplinary tumour boards (MTB) on the clinicopathological characteristics and outcomes of resected colorectal liver metastases across time
por: Chen, Lionel, et al.
Publicado: (2020)

Mouse Tumor Biology Database (MTB): status update and future directions
por: Begley, Dale A., et al.
Publicado: (2007)

An Act to Establish a Board of Pharmaceutic Examiners
Publicado: (1881)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
por: Diriba, Kuma, et al.
Publicado: (2021)

SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics
por: Singer, Franziska, et al.
Publicado: (2018)

Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia
por: Kebede, Abebaw, et al.
Publicado: (2019)

Development of a “meta-model” to address missing data, predict patient-specific cancer survival and provide a foundation for clinical decision support
por: Baron, Jason M, et al.
Publicado: (2020)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

The New Medical Practice Act—The Mixed Board Bill
Publicado: (1907)

Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection
por: Italia, Alice, et al.
Publicado: (2023)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Evaluation of the Roche cobas MTB and MTB-RIF/INH Assays in Samples from Germany and Sierra Leone
por: Nadarajan, Darshaalini, et al.
Publicado: (2021)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

The personalized cancer network explorer (PeCaX) as a visual analytics tool to support molecular tumor boards
por: Figaschewski, Mirjam, et al.
Publicado: (2023)

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
por: Ponnudurai, Nirros, et al.
Publicado: (2018)

Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study
por: Wasihun, Araya Gebreyesus, et al.
Publicado: (2020)

Implementation and utilization of the molecular tumor board to guide precision medicine
por: Harada, Shuko, et al.
Publicado: (2017)

Clinical Outcomes of Molecular Tumor Boards: A Systematic Review
por: Larson, Kara L., et al.
Publicado: (2021)

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer
por: Behel, Vichitra, et al.
Publicado: (2022)

Mouse Tumor Biology (MTB): a database of mouse models for human cancer
por: Bult, Carol J., et al.
Publicado: (2014)

Vaccine strategies for the Mtb/HIV copandemic
por: Sharan, Riti, et al.
Publicado: (2020)

Infantile ZFTA Fusion–Positive Tumor of the Posterior Fossa: Molecular Tumor Board
por: Paulson, Vera A., et al.
Publicado: (2023)

The Central Poor-Law Conference: Boards of Guardians and the Insurance Act
Publicado: (1914)

An Act to Establish a State Board of Medical Examiners and Licensers
Publicado: (1885)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Temperament and Character in Euthymic Major Depressive Disorder Patients: The Effect of Previous Suicide Attempts and Psychotic Mood Episodes
por: Ekinci, Okan, et al.
Publicado: (2012)

Systematic comparison of differential expression networks in MTB mono-, HIV mono- and MTB/HIV co-infections for drug repurposing
por: Jiang, Yao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v4ig4kt3fs1mc1v8nhfr4h75tm